Companies advised
Get value from day one
Invest with conviction.
Build on what's possible.
We help private equity, growth equity and strategic investors validate investment theses, uncover growth opportunities and focus portfolio decisions where they can create the greatest value.
Why Lemon
A strategist's lens, an operator's bias for action.
We've worked on both sides of the table—as founders, executives, analysts and advisors. We understand what investors need to know and what leadership teams need to act: a clear view of the market, honest tradeoffs and priorities that hold up beyond the boardroom.
B2B buyers researched
Investment & M&A supported
Product portfolio transformations
The Lemon Clarity Portfolio Diagnostic for Investors
One clear read across your whole portfolio.
We connect each company’s leadership strategy with customer and market evidence, then bring the findings into one portfolio view. The same approach across every company gives your investment team a consistent basis for understanding performance, spotting patterns and deciding where to focus.
Run it once to establish a baseline, or annually to track progress, catch strategic drift and identify emerging opportunities.
A baseline for every company
A clear view of where each business stands, using the same diagnostic lenses so you can track meaningful changes over time.
Perspective across the portfolio
See shared challenges, differences in readiness and where targeted support or investment could make the greatest difference.
A competitive edge for each company
Give leadership teams additional insight into customer needs, competitive dynamics and overlooked opportunities to strengthen their position.
Clear priorities for action
A sequenced path for each company, giving investors, management and boards clarity on what comes first, what needs investment and what can wait.
Where we help
From diligence to exit, with evidence behind every view.
Before the deal
Commercial Diligence
Market sizing, competitive dynamics, customer concentration, growth assumptions, and the strategic questions that determine whether a deal holds up. Includes acquisition target evaluation and go-to-market risk.
After the close
Value Creation Planning
Post-close strategy, go-to-market prioritization, product roadmap alignment, capital allocation, and the initiatives that drive measurable portfolio value.
When growth stalls
Portfolio Turnaround & Acceleration
Every portfolio has companies that have drifted: growth has stalled, the story has blurred, or product and go-to-market have pulled apart. We take the bottom 25% of the portfolio and work with the investor and each leadership team to find what is really holding them back and build a focused path to recovery and growth.
Through the hold
Portfolio Intelligence
A consistent look across your portfolio. The Lemon Clarity Diagnostic gives you the same lens on every company, run annually as a check-in, so you can see how they compare and where each is struggling—alongside the market and customer intelligence that keeps you ahead of category shifts and competitive threats.
Through the hold
Board & Operating Partner Support
Independent strategic counsel for portfolio company boards and leadership teams on product, market and organizational decisions — including board creation and fractional operators.
At exit
Exit & Category Positioning
Narrative development, buyer mapping, analyst and investor positioning, market validation and roadmap work — the story that maximizes exit outcomes.
Because we've tested the thesis, we're useful to management from day one. Many investor engagements continue as executive advisory for portfolio CEOs and boards, giving the whole group a consistent level of senior support.
An advisor who already knows the thesis.
Case in point
Validated Confidence. Real Outcomes.
The model said the market was there. Was the business?
The situation. An institutional investor needed more than a market-size opinion. The decision depended on product strength, GTM readiness and leadership alignment.
What we did. Lemon evaluated acquisition targets, tested go-to-market risk and internal alignment during diligence, then stayed on after one of the largest investment rounds in the South American HCM market to shape product strategy, GTM readiness and global market identification.
What changedTwo acquisitions followed. 80% year-over-year revenue growth for five consecutive years.
Validating the vision and gaining investor confidence before a $50M+ Series D.
The situation. An investment team wanted independent validation of a popular point solution’s vision, strategy and leadership team as part of a Series D round—and a clearer view of where further investment could create value.
What we did. Assessed leadership, strategy, product and market through a Clarity Diagnostic, paired with an innovation program involving customers and employees.
What changedValidated the vision and strategy, uncovered opportunities for new lines of business and prioritized where funding should go—giving the investment group confidence in a $50M+ Series D. The work also surfaced team dynamics and product adjustments for leadership to address before they became larger obstacles.
an independent read
Evaluating a target or a portfolio company?
We can usually tell you in one conversation which questions matter most for the thesis — and how fast we can answer them.